FDA’S OFFICE OF COMBINATION PRODUCTS: ROLES, PROGRESS & CHALLENGES
ELIQUENT Expert – Mark Kramer – is the author of an article addressing the FDA’s Office of Combination Products (OCP). Mark highlights the challenges that combination products raise, and how the OCP is solving these issues.
Learn more about Mark Kramer >>
Explore ELIQUENT’s Combination Product Solutions >>
Download a PDF of this article >>
If article image does not appear – please scroll down.
Citation: Reproduced from the Journal of Medical Device Regulation, 2005, 2(3), 3 with the kind permission
of Global Regulatory Press, London, UK www.globalregulatorypress.com